416 related articles for article (PubMed ID: 16737822)
1. Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.
Molcányiová A; Stancáková A; Javorský M; Tkác I
Pharmacol Res; 2006 Sep; 54(3):203-7. PubMed ID: 16737822
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.
Tikkanen MJ; Laakso M; Ilmonen M; Helve E; Kaarsalo E; Kilkki E; Saltevo J
Diabetes Care; 1998 Apr; 21(4):477-81. PubMed ID: 9571327
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of simvastatin in patients with hypercholesterolemia (results of a Multicenter Clinical Study)].
Kukharchuk VV; Bubnova MG; Katel'nitskaia LI; Nikitin IuP; Ol'binskaia LI;
Kardiologiia; 2003; 43(5):42-7. PubMed ID: 12891239
[TBL] [Abstract][Full Text] [Related]
4. Effects of simvastatin on plasma antioxidant status and vitamins in hypercholesterolemic patients.
Shin MJ; Chung N; Lee JH; Jang Y; Park E; Jeon KI; Chung JH; Seo BY
Int J Cardiol; 2007 May; 118(2):173-7. PubMed ID: 17005272
[TBL] [Abstract][Full Text] [Related]
5. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
Bruckert E; De Gennes JL; Malbecq W; Baigts F
Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant effect of simvastatin is not enhanced by its association with alpha-tocopherol in hypercholesterolemic patients.
Pereira EC; Bertolami MC; Faludi AA; Sevanian A; Abdalla DS
Free Radic Biol Med; 2004 Nov; 37(9):1440-8. PubMed ID: 15454283
[TBL] [Abstract][Full Text] [Related]
9. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
10. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
11. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
Garmendia F; Brown AS; Reiber I; Adams PC
Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012
[TBL] [Abstract][Full Text] [Related]
12. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients.
Averna M; Zaninelli A; Le Grazie C; Gensini GF
J Clin Lipidol; 2010; 4(4):272-8. PubMed ID: 21122660
[TBL] [Abstract][Full Text] [Related]
13. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
Farnier M; Volpe M; Massaad R; Davies MJ; Allen C
Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505
[TBL] [Abstract][Full Text] [Related]
14. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.
Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P
Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197
[TBL] [Abstract][Full Text] [Related]
15. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.
Brohet C; Banai S; Alings AM; Massaad R; Davies MJ; Allen C
Curr Med Res Opin; 2005 Apr; 21(4):571-8. PubMed ID: 15899106
[TBL] [Abstract][Full Text] [Related]
16. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of ezetimibe and simvastatin in acute myocardial infarction.
Chenot F; Montant PF; Marcovitch O; Blaimont M; de Meester A; Descamps OS
Eur J Clin Invest; 2007 May; 37(5):357-63. PubMed ID: 17461981
[TBL] [Abstract][Full Text] [Related]
18. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
19. Effect of moderate and high dose simvastatin on adhesion molecules in severe hypercholesterolemia after targeting the LDL-cholesterol--a randomised, placebo-controlled study.
Vladimirova-Kitova LG; Deneva TI; Nikolov FP
Folia Med (Plovdiv); 2011; 53(2):13-21. PubMed ID: 21797102
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin and asymmetric dimethylarginine-homocysteine metabolic pathways in patients with newly detected severe hypercholesterolemia.
Vladimirova-Kitova LG; Deneva TI
Clin Lab; 2010; 56(7-8):291-302. PubMed ID: 20857893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
